Cargando…

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand

Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Q. Sue, Wood, Tim, Jelley, Lauren, Jennings, Tineke, Jefferies, Sarah, Daniells, Karen, Nesdale, Annette, Dowell, Tony, Turner, Nikki, Campbell-Stokes, Priscilla, Balm, Michelle, Dobinson, Hazel C., Grant, Cameron C., James, Shelley, Aminisani, Nayyereh, Ralston, Jacqui, Gunn, Wendy, Bocacao, Judy, Danielewicz, Jessica, Moncrieff, Tessa, McNeill, Andrea, Lopez, Liza, Waite, Ben, Kiedrzynski, Tomasz, Schrader, Hannah, Gray, Rebekah, Cook, Kayla, Currin, Danielle, Engelbrecht, Chaune, Tapurau, Whitney, Emmerton, Leigh, Martin, Maxine, Baker, Michael G., Taylor, Susan, Trenholme, Adrian, Wong, Conroy, Lawrence, Shirley, McArthur, Colin, Stanley, Alicia, Roberts, Sally, Rahnama, Fahimeh, Bennett, Jenny, Mansell, Chris, Dilcher, Meik, Werno, Anja, Grant, Jennifer, van der Linden, Antje, Youngblood, Ben, Thomas, Paul G., Webby, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881137/
https://www.ncbi.nlm.nih.gov/pubmed/33579926
http://dx.doi.org/10.1038/s41467-021-21157-9
Descripción
Sumario:Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.